Compared with PBMC control group, the mice treated with CiTE (CD3-BAFF-R-PD-L1) and CiTE (CD3-BAFF-R-PD-L1) + Chidamide showed significant tumor growth inhibition (Fig. 4B). Here, TNFRSF13C is linked to neoplasm.